If you are trying to work out whether Viking Therapeutics’ share price makes sense right now, starting with a clear view on valuation can help you decide how it fits into your portfolio.
The stock has seen sharp swings, with a 6.3% decline over the last 7 days, a 17.0% decline over 30 days, and a 9.1% decline over 1 year, even though the 3 year and 5 year returns are very large compared to the starting point.
Recent attention on Viking Therapeutics has centered on its position in the pharmaceuticals and biotech space and how the market is reacting to its development pipeline and funding needs. These themes help frame why sentiment around the stock price may have shifted over shorter periods.
